Gallily R - Search Results

1

In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma.

Fisher T, Golan H, Schiby G, PriChen S, Smoum R, Moshe I, Peshes-Yaloz N, Castiel A, Waldman D, Gallily R, Mechoulam R, Toren A. Fisher T, et al. Among authors: gallily r. Curr Oncol. 2016 Mar;23(2):S15-22. doi: 10.3747/co.23.2893. Epub 2016 Mar 16. Curr Oncol. 2016. PMID: 27022310 Free PMC article.

2

Cannabidiol: an overview of some pharmacological aspects.

Mechoulam R, Parker LA, Gallily R. Mechoulam R, et al. Among authors: gallily r. J Clin Pharmacol. 2002 Nov;42(S1):11S-19S. doi: 10.1002/j.1552-4604.2002.tb05998.x. J Clin Pharmacol. 2002. PMID: 12412831 Review.

3

Gamma-irradiation enhances apoptosis induced by cannabidiol, a non-psychotropic cannabinoid, in cultured HL-60 myeloblastic leukemia cells.

Gallily R, Even-Chena T, Katzavian G, Lehmann D, Dagan A, Mechoulam R. Gallily R, et al. Leuk Lymphoma. 2003 Oct;44(10):1767-73. doi: 10.1080/1042819031000103917. Leuk Lymphoma. 2003. PMID: 14692532

4

2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice.

Gallily R, Breuer A, Mechoulam R. Gallily R, et al. Eur J Pharmacol. 2000 Oct 6;406(1):R5-7. doi: 10.1016/s0014-2999(00)00653-1. Eur J Pharmacol. 2000. PMID: 11011050

5

Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model.

Lodzki M, Godin B, Rakou L, Mechoulam R, Gallily R, Touitou E. Lodzki M, et al. Among authors: gallily r. J Control Release. 2003 Dec 12;93(3):377-87. doi: 10.1016/j.jconrel.2003.09.001. J Control Release. 2003. PMID: 14644587

6

Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.

Weiss L, Zeira M, Reich S, Har-Noy M, Mechoulam R, Slavin S, Gallily R. Weiss L, et al. Among authors: gallily r. Autoimmunity. 2006 Mar;39(2):143-51. doi: 10.1080/08916930500356674. Autoimmunity. 2006. PMID: 16698671

7

Fenchone Derivatives as a Novel Class of CB2 Selective Ligands: Design, Synthesis, X-ray Structure and Therapeutic Potential.

Smoum R, Haj C, Hirsch S, Nemirovski A, Yekhtin Z, Bogoslavsky B, Bakshi GK, Chourasia M, Gallily R, Tam J, Mechoulam R. Smoum R, et al. Among authors: gallily r. Molecules. 2022 Feb 18;27(4):1382. doi: 10.3390/molecules27041382. Molecules. 2022. PMID: 35209170 Free PMC article.

8

Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells.

Galanti G, Fisher T, Kventsel I, Shoham J, Gallily R, Mechoulam R, Lavie G, Amariglio N, Rechavi G, Toren A. Galanti G, et al. Among authors: gallily r. Acta Oncol. 2008;47(6):1062-70. doi: 10.1080/02841860701678787. Acta Oncol. 2008. PMID: 17934890

9

HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid.

Haj CG, Sumariwalla PF, Hanuš L, Kogan NM, Yektin Z, Mechoulam R, Feldmann M, Gallily R. Haj CG, et al. Among authors: gallily r. J Pharmacol Exp Ther. 2015 Oct;355(1):66-75. doi: 10.1124/jpet.115.226100. Epub 2015 Aug 13. J Pharmacol Exp Ther. 2015. PMID: 26272937 Free PMC article.

10

Cannabidiol arrests onset of autoimmune diabetes in NOD mice.

Weiss L, Zeira M, Reich S, Slavin S, Raz I, Mechoulam R, Gallily R. Weiss L, et al. Among authors: gallily r. Neuropharmacology. 2008 Jan;54(1):244-9. doi: 10.1016/j.neuropharm.2007.06.029. Epub 2007 Jul 17. Neuropharmacology. 2008. PMID: 17714746 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

147 results

Search Page